Search research articles
Contact Us
Filters
Showing results (1041-1050 of 1,278) with videos related to
Page
of 128
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
February 1, 2006
Synthesis and evaluation of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 3: heterocyclic P3
David C Tully, Hong Liu, Phil B Alper, et al.
The Journal of Clinical Investigation
|
November 6, 2019
Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models
Santiago Ruiz, Haitian Zhao, Pallavi Chandakkar, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 1, 2006
Arylaminoethyl carbamates as a novel series of potent and selective cathepsin S inhibitors
David C Tully, Hong Liu, Arnab K Chatterjee, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 9, 2010
Discovery of novel 1H-imidazol-2-yl-pyrimidine-4,6-diamines as potential antimalarials
Xianming Deng, Advait Nagle, Tao Wu, et al.
Journal of Medicinal Chemistry
|
October 5, 2013
Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents
Ravinder Reddy Kondreddi, Jan Jiricek, Srinivasa P S Rao, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 3, 2009
Cell-based optimization of novel benzamides as potential antimalarial leads
Tao Wu, Advait Nagle, Tomoyo Sakata, et al.
Plos Pathogens
|
July 18, 2015
Utilizing Chemical Genomics to Identify Cytochrome b as a Novel Drug Target for Chagas Disease
Shilpi Khare, Steven L Roach, S Whitney Barnes, et al.
Journal of the American Chemical Society
|
October 6, 2025
Covalent Probes Reveal Small-Molecule Binding Pockets in Structured RNA and Enable Bioactive Compound Design
Sandra Kovachka, Jielei Wang, Amirhossein Taghavi, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2024
Identification of mCMQ069, a novel antimalarial with potential for a single-dose cure and/or 28-day chemoprevention
Anil K Gupta, James Pedroarena, Armen Nazarian, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 25, 2016
Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant
Rongsheng E Wang, Ying Wang, Yuhan Zhang, et al.
Page
of 128
Search research articles
Search
Showing results (1041-1050 of 1,278) with videos related to
Sort By:
Page
of 128
Bioorganic & Medicinal Chemistry Letters
|
February 1, 2006
Synthesis and evaluation of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 3: heterocyclic P3
David C Tully, Hong Liu, Phil B Alper, et al.
The Journal of Clinical Investigation
|
November 6, 2019
Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models
Santiago Ruiz, Haitian Zhao, Pallavi Chandakkar, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 1, 2006
Arylaminoethyl carbamates as a novel series of potent and selective cathepsin S inhibitors
David C Tully, Hong Liu, Arnab K Chatterjee, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 9, 2010
Discovery of novel 1H-imidazol-2-yl-pyrimidine-4,6-diamines as potential antimalarials
Xianming Deng, Advait Nagle, Tao Wu, et al.
Journal of Medicinal Chemistry
|
October 5, 2013
Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents
Ravinder Reddy Kondreddi, Jan Jiricek, Srinivasa P S Rao, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 3, 2009
Cell-based optimization of novel benzamides as potential antimalarial leads
Tao Wu, Advait Nagle, Tomoyo Sakata, et al.
Plos Pathogens
|
July 18, 2015
Utilizing Chemical Genomics to Identify Cytochrome b as a Novel Drug Target for Chagas Disease
Shilpi Khare, Steven L Roach, S Whitney Barnes, et al.
Journal of the American Chemical Society
|
October 6, 2025
Covalent Probes Reveal Small-Molecule Binding Pockets in Structured RNA and Enable Bioactive Compound Design
Sandra Kovachka, Jielei Wang, Amirhossein Taghavi, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2024
Identification of mCMQ069, a novel antimalarial with potential for a single-dose cure and/or 28-day chemoprevention
Anil K Gupta, James Pedroarena, Armen Nazarian, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 25, 2016
Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant
Rongsheng E Wang, Ying Wang, Yuhan Zhang, et al.
Page
of 128